What are pancreatic neuroendocrine cancers?

Pancreatic neuroendocrine cancers develop in the neuroendocrine cells Open a glossary item of the pancreas. Your healthcare team might call them pancreatic neuroendocrine neoplasms (NENs). But neuroendocrine cancer and neuroendocrine neoplasm mean the same thing.

There are different types of cancer that develop in the pancreas. The most common type are exocrine Open a glossary item pancreatic cancers. These start in cells that produce pancreatic digestive juices.

Pancreatic neuroendocrine cancers are much rarer. They start in the endocrine cells of the pancreas. This is where insulin Open a glossary item and other hormones Open a glossary item are made and released into the bloodstream. They are also called pancreatic neuroendocrine tumours (PNETS) or islet cell tumours.

There are 2 key groups of neuroendocrine cancer: 

  • neuroendocrine tumours (NETs) 
  • neuroendocrine carcinomas (NECs) 

NETs and NECs are very different. So it is important to know which one you have. Talk to your doctor or specialist nurse if you are not sure.

There are different types of pancreatic NETs. The 2 main groups are:

  • functioning pancreatic NETs
  • non functioning pancreatic NETs

Pancreatic neuroendocrine cancers are rare. The treatment and prognosis Open a glossary item is different to the more common type of pancreatic cancer. So it is important you know what type you have.

The pancreas

The pancreas is part of our digestive system Open a glossary item.

Diagram showing where the pancreas is in the body in relation to the other organs. This includes the stomach, liver, bowel and gallbladder.

The pancreas is quite high up in the tummy (abdomen). It lies across your body where the ribs meet at the bottom of the breastbone, just behind your stomach. It is about 6 inches long (15 centimetres) and shaped like a leaf. 

The pancreas has 3 parts:

  • the wide part is the head

  • the thin end is the tail

  • the part in the middle is the body

Diagram showing 3 parts of the pancreas

The pancreatic duct is a tube that collects the digestive juices made by the pancreas. It carries them into the first part of the bowel (duodenum).

The pancreas makes digestive juices. It also makes different types of hormones such as insulin. The part of the pancreas which produces hormones, including insulin, is called the endocrine pancreas. The part that makes digestive juices is the exocrine pancreas.

How common are pancreatic neuroendocrine cancers?

Pancreatic neuroendocrine cancers are rare pancreatic cancers. Around 400 people are diagnosed with pancreatic neuroendocrine cancers in England every year.

There are different types of cancer that can develop in the pancreas. Only 1 to 2 out of every 100 pancreatic cancers (1 to 2%) are a pancreatic neuroendocrine cancer.

Neuroendocrine cancers can start in different parts of the body. Around 8 out of every 100 neuroendocrine cancers (around 8%) start in the pancreas.

Risks and causes of pancreatic neuroendocrine cancers

A risk factor is anything that increases your risk of getting a disease. But having one of these risk factors doesn’t mean that you will definitely develop a cancer. 

We don’t know what causes most neuroendocrine cancers. But there are some risks factors that can increase your risk of developing it. Having one of these risk factors doesn’t mean that you will definitely develop a cancer. 

The risk factors for pancreatic neuroendocrine cancer include:

  • inherited conditions such as multiple endocrine neoplasia 1 (MEN1 Open a glossary item) and Von Hippel-Lindau (VHL Open a glossary item)
  • having a family history of cancer 

Symptoms of pancreatic neuroendocrine cancer

Symptoms are usually caused by:

  • the growth of the cancer in your pancreas
  • cancer spreading to another part of your body
  • hormones made by the cancer

You might hear the terms ‘functioning’ and ‘non functioning’ neuroendocrine tumour (NET). This refers to whether the cancer over produces hormones. These hormones cause symptoms.

  • Non functioning NETs don’t over produce hormones or cause a syndrome.
  • Functioning NETs over produce certain hormones. This causes a group of symptoms called a syndrome.

We have a page for each type of pancreatic NET. You can read more about the symptoms of each type on the relevant page.

Cancer in your pancreas can cause some general symptoms. These might include:

  • tummy pain
  • unexplained weight loss
  • loss of appetite
  • indigestion (dyspepsia)
  • yellowing of the skin and whites of the eyes (jaundice)

These symptoms could be due to a pancreatic neuroendocrine cancer. But they can also be caused by other medical conditions. It’s important to get them checked out by your doctor.

Getting diagnosed with a pancreatic neuroendocrine cancer

You have some tests to diagnose a neuroendocrine cancer of the pancreas. This might include blood tests and scans. Your GP can refer you to see a specialist.

If your doctor suspects cancer, you have tests to check the type of cancer you have. Tests also show the size of the cancer and whether it has spread. This helps your doctor plan your treatment.

Tests might include:

  • blood tests - these check your general health and check levels of substances raised by neuroendocrine cancer
  • a CT scan Open a glossary item
  • an MRI scan Open a glossary item
  • an endoscopic ultrasound scan Open a glossary item of your tummy to look at your stomach, pancreas and bile ducts, and to take biopsies Open a glossary item
  • a PET-CT scan Open a glossary item to show the size of the cancer and whether it has spread
  • radioactive scans – these include octreotide scans Open a glossary item or Tektrotyd scans, and gallium PET scans
  • urine tests to check levels of substances raised by neuroendocrine cancer

You might have other tests, depending on your symptoms. Your doctor can tell you which tests you need.

Survival (prognosis)

The best person to talk to you about your outlook (prognosis) is your doctor. Not everyone wants to know. People cope differently with cancer and want different information.

Survival depends on many factors. So no one can tell you exactly how long you will live. Your doctor might be able to give you some guide, based on their knowledge and experience.

Your prognosis will depend on the type of pancreatic neuroendocrine cancer you have. And how far it has spread (the stage).

Grades, types and stages of pancreatic neuroendocrine cancer

The tests and scans you have give information about the type, stage Open a glossary item and grade. This helps your doctor decide which treatment you need. 

There are 2 main groups of pancreatic neuroendocrine cancer:

  • pancreatic neuroendocrine tumours (NETs)
  • pancreatic neuroendocrine carcinoma (NECs)

Types of pancreatic NETS

There are many different types of pancreatic neuroendocrine tumours (NETs):

  • Glucagonomas come from cells that make glucagon.
  • Gastrinomas come from cells that make gastrin. 
  • Insulinomas come from cells that make insulin.
  • Somatostatinomas come from cells that make somatostatin.
  • VIPomas come from cells that make vasoactive intestinal peptide (VIP).

Pancreatic neuroendocrine carcinomas (NECs)

NECs are poorly differentiated cancers. This means the cancer cells look very different to normal neuroendocrine cells. They are fast growing and have often spread to other parts of the body at diagnosis.

  • Incidence and survival of neuroendocrine neoplasia in England 1995-2018: A retrospective, population-based study
    B White and others
    Lancet Regional Health Europe, 2022. Volume 23, Pages 1 - 11

  • Classification, clinical presentation, diagnosis, and staging of pancreatic neuroendocrine neoplasms
    J Strosberg
    UpToDate, accessed October 2024

  • Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
    Z Ma and others
    World Journal of Gastroenterology, 2020. Volume 26, Issue 19, Pages 2305 - 2322

  • European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for non functioning pancreatic neuroendocrine tumours
    B Kos-Kudla and others
    Journal of Neuroendocrinology, 2023. Volume 35, Issue 12, Page e13343  

  • Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma
    H Sorbye and J Strosberg
    UpToDate, accessed March 2025

Last reviewed: 
30 Apr 2025
Next review due: 
30 Apr 2028

Related links